FDA Launches Effort to Ease Approval Pathway for Biosimilars

(MedPage Today) — Federal regulators are trying to make it easier to develop cheaper alternatives to biologics that many Americans depend on to treat autoimmune diseases or cancers.
The FDA said Wednesday it has released guidance to simplify…

Source link : https://www.medpagetoday.com/publichealthpolicy/fdageneral/118219

Author :

Publish date : 2025-10-29 20:21:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

FDA Launches Effort to Ease Approval Pathway for Biosimilars

A Cooler Pancreas? Device Shows Promise in Early-Stage Trial

NHS Opt-Out Tests Identify Undiagnosed Infections

Related Posts

PSA Screening Reduces Prostate Cancer Deaths, Long-Term Data Show

Adding Physical Therapy Did Not Further Reduce Knee Pain From Meniscal Tear

NHS Opt-Out Tests Identify Undiagnosed Infections

A Cooler Pancreas? Device Shows Promise in Early-Stage Trial

Review Finds Manicures Often Linked to Adverse Reactions

Recent Developments in Retinal Disease

Adding Physical Therapy Did Not Further Reduce Knee Pain From Meniscal Tear

PSA Screening Reduces Prostate Cancer Deaths, Long-Term Data Show

NHS Opt-Out Tests Identify Undiagnosed Infections

FDA Launches Effort to Ease Approval Pathway for Biosimilars

A Cooler Pancreas? Device Shows Promise in Early-Stage Trial

Review Finds Manicures Often Linked to Adverse Reactions

Recent Developments in Retinal Disease

A Journal Promised to Retract a Flawed Autism Study. It’s Still Online.

Categories

Archives